Page last updated: 2024-09-05

enrasentan and Hypertrophy, Right Ventricular

enrasentan has been researched along with Hypertrophy, Right Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engelberts, D; Jankov, RP; Kantores, C; Kavanagh, BP; McNamara, PJ; Murthy, P; Teixeira, L1
Bochnowicz, S; Elliott, JD; Hart, TK; Hay, DW; Louden, CS; Luttmann, MA; Osborn, RR; Underwood, DC1

Other Studies

2 other study(ies) available for enrasentan and Hypertrophy, Right Ventricular

ArticleYear
Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat.
    American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 291, Issue:5

    Topics: Animals; Animals, Newborn; Body Weight; Carbon Dioxide; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Female; Hematocrit; Hypercapnia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Oxidative Stress; Oxygen; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Rats; Up-Regulation

2006
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
    Pulmonary pharmacology & therapeutics, 1999, Volume: 12, Issue:1

    Topics: Altitude; Animals; Benzofurans; Carboxylic Acids; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Male; Propionates; Pulmonary Artery; Pyrrolidines; Random Allocation; Rats; Receptors, Endothelin

1999